Summary
This 2022 narrative review in Thrombosis Research examines the intersection of cancer and stroke, focusing on thrombotic mechanisms that may explain their clinical association. The authors appear to synthesise current knowledge on how malignancy increases stroke risk and discuss gaps in understanding. The work aims to chart future research directions in this under-explored area of cancer-associated thromboembolism.
UK applicability
The findings are relevant to UK clinical practice and epidemiology, particularly for stroke and oncology services managing patients at risk of thrombotic complications. However, applicability depends on whether the review addresses UK-specific incidence data or healthcare system considerations.
Key measures
As suggested by the title, the paper likely examines thrombotic biomarkers, incidence rates, mechanistic pathways, and clinical outcomes associated with cancer-stroke comorbidity.
Outcomes reported
The study appears to review the current understanding of thrombotic pathways that connect cancer and stroke as linked clinical outcomes. The paper likely examines shared mechanisms and identifies evidence gaps in the literature.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.